Using standard risk B-cell acute lymphoblastic leukemia (SR B-ALL) as baseline, we examined the expression of receptor and ligands on circulating T cells between the two disease groups and found no statistically significant difference between overall expression of PD-1, TIM-3, or LAG-3 (Figure 4). This evidence concerns the gene HAVCR2 and acute lymphoblastic leukemia.